Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL704371 | 0.87 | KCNA3 (0.41) | KCNA3CA4HTR1BLTA4H | |
| SCHEMBL705384 | 0.83 | KCNA3 (0.41) | KCNA3CA4HTR1BLTA4H | |
| SCHEMBL705837 | 0.79 | CA4 (0.42) | KCNA3CA4HTR1BLTA4H | |
| SCHEMBL1608982 | 0.78 | LTA4H (0.46) | KCNA3LTA4H | |
| SCHEMBL13089622 | 0.78 | — | — | |
| SCHEMBL3350911 | 0.77 | HDAC3 (0.46) | KCNA3CA4HTR1BLTA4H | |
| SCHEMBL3917624 | 0.77 | KCNA3 (0.35) | KCNA3CA4HTR1BLTA4H | |
| SCHEMBL3923262 | 0.77 | KCNA3 (0.40) | KCNA3CA4HTR1BLTA4H | |
| SCHEMBL3815414 | 0.77 | TAAR1 (0.41) | KCNA3LTA4H | |
| SCHEMBL10568290 | 0.76 | LTA4H (0.36) | KCNA3CA4HTR1BLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261925-A1 | METHOD FOR PRODUCING SILICON COMPOUND | JSR CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261925-A1 | METHOD FOR PRODUCING SILICON COMPOUND | GMNN, GEMIN5, SEPTIN7 | KCNA3 2287/4885CA4 147/4885HTR1B 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.